RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

The RAPS store will be under maintenance Saturday, 13 June between 6 AM and 12 PM EST. Store functionality may be unavailable at times during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > Regulatory Advice

Regulatory Advice

Posted 01 December 2009 | By

The European Directorate for the Quality of Medicines and Healthcare (EDQM) has relatively recently updated the way in which it handles new applications for Certification of Suitability to the Monograph of the European Pharmacopoeia (CEP). Beginning September of 2008, EDQM decided to apply the procedure for managing the certification scheme described in the Resolution AP CSP (07) 1 in a more rigorous fashion to ensure that official timelines are met. The evaluation of new dossiers is now handled in two phases.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.